JAC Advance Access originally published online on February 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 533-535
© 2004 The British Society for Antimicrobial Chemotherapy
Diffusion of levofloxacin into bone and synovial tissues
1 Department of Anaesthesiology and Intensive Care, Hôtel-Dieu Hospital, Lyon; 2 Clinical Pharmacokinetics Laboratory, Haut-Lévêque Hospital, Pessac; Departments of 3 Orthopaedic Surgery and 4 Anaesthesiology and Intensive Care, Edouard Herriot Hospital, Lyon, France
Received 13 August 2003; returned 4 November 2003; revised 4 December 2003; accepted 13 December 2003
Objectives: The degree of penetration of an antibiotic into the infected site is an important determinant of therapeutic success. Levofloxacin is widely used in the treatment of serious infections. However, there are only few studies concerning its diffusion into bone tissue and none concerning its diffusion into synovial tissue. Our objective was to quantify levofloxacin bone and synovial tissue penetration and to compare our data with the breakpoint for susceptible organisms.
Patients and methods: In an open-label study, 12 subjects who were undergoing elective total hip replacement received a single, parenteral, 500 mg dose of levofloxacin. Plasma, cortical and cancellous bone, and synovial tissue samples were collected a mean of 1.2 h later and analysed by a validated HPLC method.
Results: The mean ± S.D. plasma concentration of levofloxacin at the time of bone removal was 7.5 ± 1.3 mg/L. The levofloxacin concentrations were 7.4 ± 2.2 mg/kg in cancellous bone tissue and 3.9 ± 1.2 mg/kg in cortical bone tissue. The levofloxacin concentration was 8.9 ± 2.1 mg/kg in synovial tissue. The mean ± S.D. ratios of levofloxacin concentration in bone and plasma (bone/plasma) were 1.0 ± 0.4 for cancellous bone tissue and 0.5 ± 0.1 for cortical bone tissue. The ratio of levofloxacin concentration in synovial tissue and plasma (synovial tissue/plasma) was 1.2 ± 0.4.
Conclusions: The concentrations of levofloxacin achieved in cancellous and cortical bone tissue and in synovial tissue are greater than the breakpoint for susceptible organisms, which is 
2 mg/L.
Keywords: levofloxacin, diffusion, bone and synovial tissues, pharmacokinetics, bone and joint infections
* Corresponding author. Tel: +33-472-413-170; Fax +33-472-413-135; E-mail: emmanuel.boselli{at}chu-lyon.fr
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. C. Martinez-Pastor, E. Munoz-Mahamud, F. Vilchez, S. Garcia-Ramiro, G. Bori, J. Sierra, J. A. Martinez, L. Font, J. Mensa, and A. Soriano Outcome of Acute Prosthetic Joint Infections Due to Gram-Negative Bacilli Treated with Open Debridement and Retention of the Prosthesis Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4772 - 4777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Denes, A. Boumediene, H. Durox, A. Oksman, F. Saint-Marcoux, M.-L. Darde, and J.-M. Gaulier Voriconazole concentrations in synovial fluid and bone tissues J. Antimicrob. Chemother., April 1, 2007; 59(4): 818 - 819. [Full Text] [PDF]
|
|